Synaptogenix, Inc.
New York, NY Doing business as Neurotrope
- UEI
- LQ2CHPJK6P85
- CAGE
- 78S29
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1185 6th Ave 3rd Fl, New York, NY 10036, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Long-term therapeutic effects of synthetic bryostatin-1 in advanced ad without memantine | National Institute on Aging (NIH) | $6,168,271 |
Quick answers
Is Synaptogenix, Inc. registered in SAM.gov?
Yes. Synaptogenix, Inc.'s SAM.gov registration is active through June 3, 2027.
What is Synaptogenix, Inc.'s most recent federal award?
Synaptogenix, Inc.'s most recent federal grant award is Long-term therapeutic effects of synthetic bryostatin-1 in advanced ad without memantine (R44AG066366), from National Institute on Aging (NIH), on September 30, 2019.
On GovTribe
See Synaptogenix, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors